10月28日，康希诺生物绩后涨近5%！前三季度实现营业收入6.93亿元，同比增长22.13%。
10月27日，康希诺生物发布前三季度业绩，截至2025年9月30日止九个月实现营业收入6.93亿元，同比增长22.13%；归属于上市公司股东的净利润为1444.01万元，上年同期净亏损为2.22亿元。基本每股收益0.06元。
值得一提的是，据康希诺生物官微消息，10月28日至30日，全球最大的制药行业专业展览会——世界制药原料展览会CPHI Europe 2025将在德国法兰克福举行。康希诺生物将携自主研发的丰富产品线参会，全方位呈现在创新肺炎疫苗、脑膜炎疫苗及组分百白破联合疫苗等关键领域的突出优势和深厚积累，并开启在全球疫苗CRDMO领域的创新合作与业务拓展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
